 |
 |

Management of Cancer Pain
 |
 |
| Since this article does not have an abstract, we have provided the first 30 words of the full text and any section headings. |
|
 |
 |
To the Editor: Drs Bruera and Kim1 did not mention intrathecal opioid infusion, which can be used to manage cancer pain while avoiding many of the usual opioid-related adverse effects.2-4
Joshua M. Rosenow, MD
jrosenow@nmff.org Department of Neurosurgery Northwestern University Feinberg School of Medicine Chicago, Ill
1. Bruera E, Kim HN. Cancer pain. JAMA. 2003;290:2476-2479.
FREE FULL TEXT
2. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage. 1996;11:71-80.
FULL TEXT
|
ISI
| PUBMED
3. Smith TJ, Staats PS, Deer T, et al, for the Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040-4049.
FREE FULL TEXT
4. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery. 1999;44:289-300; discussion 300-301.
FULL TEXT
|
ISI
| PUBMED
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
JAMA. 2004;291:1068.
RELATED ARTICLES
Management of Cancer Pain
Allen W. Burton, Arun Rajagopal, Charles S. Cleeland, Samuel J. Hassenbusch, III, and Daniel B. Carr
JAMA. 2004;291(9):1067-1068.
EXTRACT
| FULL TEXT
Management of Cancer Pain
Chris Flores
JAMA. 2004;291(9):1068.
EXTRACT
| FULL TEXT
Management of Cancer PainReply
Eduardo Bruera
JAMA. 2004;291(9):1068-1069.
EXTRACT
| FULL TEXT
Cancer Pain
Eduardo Bruera and Hak Nam Kim
JAMA. 2003;290(18):2476-2479.
EXTRACT
| FULL TEXT
|